This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Opdivo
  • /
  • Efficacy Study of Nivolumab Compared to Ipilimumab...
Clinical trial

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma (CheckMate 238)

Read time: 2 mins
Last updated:12th Mar 2015
Identifier: NCT02388906
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest